Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. Stryker Biotech settles federal beef for $15M
Stryker Biotech agreed to cough up $15 million and and pleaded guilty to a single misdemeanor today, ending federal charges that it ran an illegal off-label promotion scheme.
6. More J&J execs deposed in DePuy lawsuit
Several additional Johnson & Johnson (NYSE:JNJ) executives were deposed for questioning in the ongoing lawsuits regarding subsidiary DePuy Orthopaedics’ ASR metal-on-metal implants.
5. Cardiovascular leaders to huddle on Riata recall
Physicians from the Minneapolis Heart Institute Foundation and the Mayo Clinic will huddle with electrophysiologists in the Twin Cities Jan. 20 to discuss strategies for dealing with the recall of the Riata defibrillator leads made by St. Jude Medical (NYSE:STJ).
4. Leave emerging markets to the big dogs, say med-tech CEOs
Emerging markets are a tempting prospect for med-tech companies hoping to compensate for slowing growth in the U.S. and Europe, but it’s no game for small players, according to a panel of large-cap CEOs.
3. Depuy shuts down custom orthopedics after FDA warning
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics decided to stop selling all custom fitted devices in response to an FDA warning following an inspection of the Warsaw, Ind.-based company’s facilities.
2. Johnson & Johnson hit with FDA warning letter
More regulatory woes as the FDA issued a warning letter to medical device giant Johnson & Johnson (NYSE:JNJ) saying that the company failed to report incidents where its OneTouch Ping and 2020 insulin pumps may have caused death or serious injury.
1. Covidien recalls Duet following deaths, injuries
Covidien plc (NYSE:COV) launched a recall of the entire production lot of its Duet TRS single-use heads for thoracic surgery after the company received reports of 13 serious injuries and 3 deaths following use.
